Crinetics Pharmaceuticals (CRNX) Short Interest Ratio & Short Volume $29.44 +1.01 (+3.55%) Closing price 07/2/2025 04:00 PM EasternExtended Trading$29.45 +0.01 (+0.03%) As of 07/2/2025 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Crinetics Pharmaceuticals Short Interest DataCrinetics Pharmaceuticals (CRNX) has a short interest of 10.32 million shares, representing 11.55% of the float (the number of shares available for trading by the public). This marks a 1.08% increase in short interest from the previous month. The short interest ratio (days to cover) is 11.5, indicating that it would take 11.5 days of the average trading volume of 817,851 shares to cover all short positions.Current Short Interest10,320,000 sharesPrevious Short Interest10,210,000 sharesChange Vs. Previous Month+1.08%Dollar Volume Sold Short$327.87 millionShort Interest Ratio11.5 Days to CoverLast Record DateJune 15, 2025Outstanding Shares93,630,000 sharesShort Percent of Float11.55%Today's Trading Volume867,380 sharesAverage Trading Volume817,851 sharesToday's Volume Vs. Average106% Short Selling Crinetics Pharmaceuticals? Sign up to receive the latest short interest report for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCRNX Short Interest Over TimeCRNX Days to Cover Over TimeCRNX Percentage of Float Shorted Over Time Crinetics Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/202510,320,000 shares $327.87 million +1.1%11.6%11.5 $31.77 5/31/202510,210,000 shares $312.32 million +0.5%11.7%10.6 $30.59 5/15/202510,160,000 shares $317.09 million +3.3%11.7%9.8 $31.21 4/30/20259,840,000 shares $328.56 million +2.2%N/A9.7 $33.39 4/15/20259,630,000 shares $285.63 million +12.8%11.0%9.6 $29.66 3/31/20258,540,000 shares $286.43 million +9.9%9.8%7.8 $33.54 3/15/20257,770,000 shares $267.83 million -4.2%8.9%7.9 $34.47 2/28/20258,110,000 shares $290.18 million +4.0%9.3%8.6 $35.78 2/15/20257,800,000 shares $274.64 million +5.7%8.9%9.1 $35.21 1/31/20257,380,000 shares $297.41 million +2.9%N/A8.7 $40.30 Get the Latest News and Ratings for CRNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20257,170,000 shares $263.35 million +3.6%N/A8.9 $36.73 12/31/20246,920,000 shares $353.82 million +10.7%N/A8.9 $51.13 12/15/20246,250,000 shares $335.38 million +4.0%N/A8.4 $53.66 11/30/20246,010,000 shares $343.77 million -7.5%N/A8.4 $57.20 11/15/20246,500,000 shares $355.68 million -6.3%N/A9.1 $54.72 10/31/20246,940,000 shares $388.36 million +5.3%N/A10.5 $55.96 10/15/20246,590,000 shares $379.58 million -2.8%N/A9.8 $57.60 9/30/20246,780,000 shares $346.46 million +11.0%N/A10.3 $51.10 9/15/20246,110,000 shares $328.72 million -1.8%N/A8.2 $53.80 8/31/20246,220,000 shares $330.03 million -3.9%N/A8.3 $53.06 8/15/20246,470,000 shares $339.87 million +5.7%N/A8 $52.53 7/31/20246,120,000 shares $325.09 million -7.0%N/A6.6 $53.12 7/15/20246,580,000 shares $356.24 million +12.1%N/A7 $54.14 6/30/20245,870,000 shares $262.92 million +0.2%N/A6.5 $44.79 6/15/20245,860,000 shares $265.63 million +16.5%N/A6.7 $45.33 5/31/20245,030,000 shares $223.38 million +2.4%N/A5.6 $44.41 5/15/20244,910,000 shares $247.91 million No ChangeN/A5.5 $50.49 4/30/20244,910,000 shares $215.16 million -5.9%N/A5.9 $43.82 4/15/20245,220,000 shares $228.01 million +6.3%N/A6.5 $43.68 3/31/20244,910,000 shares $229.84 million -2.0%N/A6.1 $46.81 3/15/20245,010,000 shares $195.04 million +5.7%N/A6.7 $38.93 2/29/20244,740,000 shares $194.06 million +5.1%N/A6 $40.94 2/15/20244,510,000 shares $166.51 million -11.1%N/A5.8 $36.92 1/31/20245,070,000 shares $184.95 million -0.8%N/A6.2 $36.48 1/15/20245,110,000 shares $190.04 million -0.6%N/A6 $37.19 12/31/20235,140,000 shares $182.88 million -13.6%N/A5.9 $35.58 12/15/20235,950,000 shares $205.04 million -6.7%N/A6.4 $34.46 11/30/20236,380,000 shares $202.82 million +2.9%N/A4 $31.79 11/15/20236,200,000 shares $179.06 million -7.6%N/A4 $28.88 10/31/20236,710,000 shares $196.54 million -1.5%N/A4.4 $29.29Trump Makes Major Crypto Announcement (Ad)Pay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong. One project stands to benefit more than any other – not by accident, but seemingly by design. Click Here to Discover our #1 crypto for the Trump Presidency Bull Run now! 10/15/20236,810,000 shares $198.24 million +16.4%N/A4.7 $29.11 9/30/20235,850,000 shares $173.98 million +43.7%N/A4.1 $29.74 9/15/20234,070,000 shares $120.02 million -10.4%N/A3.1 $29.49 8/31/20234,540,000 shares $78.63 million +21.4%N/A5.2 $17.32 8/15/20233,740,000 shares $62.53 million +11.0%N/A7.9 $16.72 7/31/20233,370,000 shares $64.03 million -2.9%N/A7.2 $19.00 7/15/20233,470,000 shares $70.68 million +1.5%N/A7.2 $20.37 6/30/20233,420,000 shares $61.63 million +4.0%N/A7.6 $18.02 6/15/20233,290,000 shares $68.33 million No ChangeN/A7 $20.77 5/31/20233,290,000 shares $71.82 million -4.4%N/A7.2 $21.83 5/15/20233,440,000 shares $76.82 million -18.9%N/A7.7 $22.33 4/30/20234,240,000 shares $82.85 million -1.2%N/A9.9 $19.54 4/15/20234,290,000 shares $68.34 million -6.3%N/A10.6 $15.93 3/31/20234,580,000 shares $73.55 million +12.3%N/A10.8 $16.06 3/15/20234,080,000 shares $70.14 million +12.1%N/A10.1 $17.19 2/28/20233,640,000 shares $71.49 million +7.4%N/A8.9 $19.64 2/15/20233,390,000 shares $67.70 million -4.0%N/A8.8 $19.97 1/31/20233,530,000 shares $69.22 million -5.4%N/A9.3 $19.61 1/15/20233,730,000 shares $67.29 million No ChangeN/A11.1 $18.04 12/30/20223,730,000 shares $68.26 million +3.3%N/A11.7 $18.30 12/15/20223,610,000 shares $58.63 million -5.3%N/A12.1 $16.24 11/30/20223,810,000 shares $68.08 million -1.3%N/A14.3 $17.87 11/15/20223,860,000 shares $70.41 million -3.7%N/A14.3 $18.24 10/31/20224,010,000 shares $74.02 million -1.7%N/A14.4 $18.46 10/15/20224,080,000 shares $72.05 million +1.5%N/A15 $17.66 9/30/20224,020,000 shares $78.95 million +3.1%N/A15.6 $19.64 9/15/20223,900,000 shares $83.34 million +9.9%N/A14 $21.37 8/31/20223,550,000 shares $67.02 million +13.4%N/A12.3 $18.88 8/15/20223,130,000 shares $70.02 million +12.6%N/A10.3 $22.37 7/31/20222,780,000 shares $53.40 million -2.1%N/A8.9 $19.21 7/15/20222,840,000 shares $58.82 million -1.1%N/A9 $20.71 6/30/20222,870,000 shares $53.53 million +5.9%N/A8.3 $18.65 6/15/20222,710,000 shares $47.86 million +8.8%N/A7.4 $17.66 5/31/20222,490,000 shares $41.71 million +2.1%N/A7.5 $16.75 5/15/20222,440,000 shares $45.75 million +11.9%N/A7.9 $18.75 4/30/20222,180,000 shares $44.30 million -18.1%N/A7.9 $20.32 4/15/20222,660,000 shares $69.16 million +0.8%N/A9.5 $26.00 3/31/20222,640,000 shares $57.95 million +13.3%N/A10.7 $21.95 3/15/20222,330,000 shares $44.46 million +10.4%6.2%9.6 $19.08 2/28/20222,110,000 shares $42.24 million +0.5%5.6%8.1 $20.02 2/15/20222,100,000 shares $41.43 million +23.5%5.6%7.6 $19.73 1/31/20221,700,000 shares $32.11 million +39.3%N/A6.1 $18.89 1/15/20221,220,000 shares $29.29 million -6.9%N/A4.3 $24.01 12/31/20211,310,000 shares $37.22 million +12.0%N/A4.1 $28.41 12/15/20211,170,000 shares $29.45 million +18.1%N/A3.8 $25.17 11/30/2021990,900 shares $27.07 million -1.9%N/A3.6 $27.32 11/15/20211,010,000 shares $27.26 million -13.7%N/A3.8 $26.99 10/29/20211,170,000 shares $29.17 million -17.0%3.4%4.4 $24.93 10/15/20211,410,000 shares $27.48 million -4.7%4.8%5.7 $19.49 9/30/20211,480,000 shares $31.15 million +16.5%5.0%8.5 $21.05Trump Makes Major Crypto Announcement (Ad)Pay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong. One project stands to benefit more than any other – not by accident, but seemingly by design. Click Here to Discover our #1 crypto for the Trump Presidency Bull Run now! 9/15/20211,270,000 shares $29.85 million -3.1%4.3%6.7 $23.50 8/31/20211,310,000 shares $30.88 million +5.7%4.7%6.7 $23.57 8/13/20211,240,000 shares $27.60 million -4.6%4.4%6.3 $22.26 7/30/20211,300,000 shares $23.37 million -0.8%4.9%7.8 $17.98 7/15/20211,310,000 shares $25.82 million -3.7%4.5%8.2 $19.71 6/30/20211,360,000 shares $25.64 million +2.3%4.7%7.9 $18.85 6/15/20211,330,000 shares $24.25 million -8.3%4.6%7.9 $18.23 5/28/20211,450,000 shares $25.45 million -4.6%5.0%10.2 $17.55 5/14/20211,520,000 shares $24.17 million -0.7%N/A12 $15.90 4/30/20211,530,000 shares $27.17 million -0.7%N/A11.1 $17.76 4/15/20211,540,000 shares $25.29 million +2.0%N/A11.1 $16.42 3/31/20211,510,000 shares $23.31 million -2.6%N/A11 $15.44 3/15/20211,550,000 shares $26.24 million +1.3%N/A11.1 $16.93 2/26/20211,530,000 shares $23.03 million +10.9%N/A11.2 $15.05 2/12/20211,380,000 shares $23.78 million -7.4%N/A9 $17.23 1/29/20211,490,000 shares $22.22 million +2.1%N/A9.5 $14.91 1/15/20211,460,000 shares $21.58 million +1.4%N/A8.3 $14.78 12/31/20201,440,000 shares $19.71 million +9.9%N/A8.2 $13.69 12/15/20201,310,000 shares $17.99 million +0.8%N/A8.1 $13.73 11/30/20201,300,000 shares $18.67 million +3.2%N/A8.8 $14.36 11/15/20201,260,000 shares $16.23 million +7.7%N/A9.1 $12.88 10/30/20201,170,000 shares $14.60 million -14.6%N/A9.9 $12.48 10/15/20201,370,000 shares $22.15 million -3.5%N/A13.2 $16.17 9/30/20201,420,000 shares $22.25 million +2.2%N/A14.3 $15.67 9/15/20201,390,000 shares $22.27 million -3.5%N/A8.7 $16.02 8/31/20201,440,000 shares $23.08 million -0.7%N/A7.6 $16.03 8/14/20201,450,000 shares $22.05 million -2.7%N/A7.1 $15.21 7/31/20201,490,000 shares $20.68 million -15.8%N/A6.8 $13.88 7/15/20201,770,000 shares $26.92 million -30.3%N/A8.1 $15.21 CRNX Short Interest - Frequently Asked Questions What is Crinetics Pharmaceuticals' current short interest? Short interest is the volume of Crinetics Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 10,320,000 shares of CRNX short. 11.55% of Crinetics Pharmaceuticals' shares are currently sold short. Learn More on Crinetics Pharmaceuticals' current short interest. What is a good short interest ratio for Crinetics Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRNX shares currently have a short interest ratio of 12.0. Learn More on Crinetics Pharmaceuticals's short interest ratio. Which institutional investors are shorting Crinetics Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Crinetics Pharmaceuticals: Caption Management LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Crinetics Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.55% of Crinetics Pharmaceuticals' floating shares are currently sold short. Is Crinetics Pharmaceuticals' short interest increasing or decreasing? Crinetics Pharmaceuticals saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 10,320,000 shares, an increase of 1.1% from the previous total of 10,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Crinetics Pharmaceuticals' short interest compare to its competitors? 11.55% of Crinetics Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Crinetics Pharmaceuticals: Ascendis Pharma A/S (7.33%), Viatris Inc. (3.74%), Qiagen N.V. (2.63%), Moderna, Inc. (18.56%), Blueprint Medicines Corporation (5.06%), BridgeBio Pharma, Inc. (13.60%), Verona Pharma PLC American Depositary Share (10.39%), Roivant Sciences Ltd. (10.75%), Revolution Medicines, Inc. (10.62%), Elanco Animal Health Incorporated (4.93%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Crinetics Pharmaceuticals stock? Short selling CRNX is an investing strategy that aims to generate trading profit from Crinetics Pharmaceuticals as its price is falling. CRNX shares are trading up $1.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Crinetics Pharmaceuticals? A short squeeze for Crinetics Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRNX, which in turn drives the price of the stock up even further. How often is Crinetics Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRNX, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies Ascendis Pharma A/S Short Interest Data Viatris Short Interest Data Qiagen Short Interest Data Moderna Short Interest Data Blueprint Medicines Short Interest Data BridgeBio Pharma Short Interest Data Verona Pharma PLC American Depositary Share Short Interest Data Roivant Sciences Short Interest Data Revolution Medicines Short Interest Data Elanco Animal Health Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CRNX) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crinetics Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crinetics Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRNX Stock Alerts